Use of sarolaner in the treatment of tungiasis in naturally infested dogs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Veterinary Medicine |
Texto Completo: | https://bjvm.org.br/BJVM/article/view/1328 |
Resumo: | Tungiasis is an endemic dermatological parasitic zoonosis in Latin America, caused by the sand flea Tunga spp. (Siphonaptera, Tungidae), which promotes intense discomfort, swelling, erythema, itching, pain, secondary bacterial infection, cellulitis and necrosis. Sarolaner has been used to control different ectoparasites, but there is no record of its use for the treatment of tungiasis in dogs. The objective of this study was to evaluate the effectiveness of sarolaner for the treatment dogs naturally infested by Tunga spp. kept in the same infested environment. Three of four animals were medicated with sarolaner orally with a single dose of 2 mg/kg, as recommended by the manufacturer, and one animal remained without medication. After 24 hours, the fleas from all four dogs were mechanically removed. The animals were reevaluated on days +15 and +30 to assess possible reinfestation. The medicated animals remained free of fleas, while the untreated animal had fleas on the days previously defined for reevaluation. We can thus conclude that the use of sarolaner is an effective choice for tungiasis treatment. |
id |
SBMV-1_441308f02723e4dd861aaea7fcc37d04 |
---|---|
oai_identifier_str |
oai:ojs.rbmv.org:article/1328 |
network_acronym_str |
SBMV-1 |
network_name_str |
Brazilian Journal of Veterinary Medicine |
repository_id_str |
|
spelling |
Use of sarolaner in the treatment of tungiasis in naturally infested dogsUso do sarolaner no tratamento de tungiase em cães naturalmente infestadosTunga spp., canine, isoxazoline, control, prophylaxis.Tunga spp., canino, isoxazolina, controle, profilaxia.Tungiasis is an endemic dermatological parasitic zoonosis in Latin America, caused by the sand flea Tunga spp. (Siphonaptera, Tungidae), which promotes intense discomfort, swelling, erythema, itching, pain, secondary bacterial infection, cellulitis and necrosis. Sarolaner has been used to control different ectoparasites, but there is no record of its use for the treatment of tungiasis in dogs. The objective of this study was to evaluate the effectiveness of sarolaner for the treatment dogs naturally infested by Tunga spp. kept in the same infested environment. Three of four animals were medicated with sarolaner orally with a single dose of 2 mg/kg, as recommended by the manufacturer, and one animal remained without medication. After 24 hours, the fleas from all four dogs were mechanically removed. The animals were reevaluated on days +15 and +30 to assess possible reinfestation. The medicated animals remained free of fleas, while the untreated animal had fleas on the days previously defined for reevaluation. We can thus conclude that the use of sarolaner is an effective choice for tungiasis treatment.Tungíase é uma zoonose parasitária dermatológica endêmica na América Latina, causada pela pulga da areia Tunga spp. (Siphonaptera, Tungidae), que promove intenso desconforto, edema, eritema, prurido, dor, infecção bacteriana secundária, celulite e necrose. Sarolaner tem sido utilizado no controle de diversos ectoparasitas, mas não existem registros de seu uso no tratamento de tungíase em cães. O objetivo deste estudo foi avaliar a eficácia do sarolaner no tratamento de cães naturalmente infestados por Tunga spp. mantidos no mesmo ambiente infestado. Três dos quatro animais foram medicados com sarolaner por via oral em dose única de 2 mg/kg, conforme recomendação do fabricante, e um animal permaneceu sem medicação. Após 24 horas, as pulgas dos quatro cães foram removidas mecanicamente. Os animais foram reavaliados nos dias +15 e +30 para avaliar uma possível reinfestação. Os animais medicados permaneceram livres de pulgas, enquanto o animal não tratado apresentou pulgas nos dias previamente definidos para reavaliação. Podemos assim concluir que o uso do sarolaner é uma escolha eficaz para o tratamento da tungíase.Sociedade de Medicina Veterinária do Estado do Rio de Janeiro.2024-03-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmlhttps://bjvm.org.br/BJVM/article/view/132810.29374/2527-2179.bjvm000224Brazilian Journal of Veterinary Medicine; Vol. 46 (2024); e000224Revista Brasileira de Medicina Veterinária; v. 46 (2024); e0002242527-21790100-2430reponame:Brazilian Journal of Veterinary Medicineinstname:Sociedade de Medicina Veterinária do Estado do Rio de Janeiro (SOMVERJ)instacron:SBMVenghttps://bjvm.org.br/BJVM/article/view/1328/1396https://bjvm.org.br/BJVM/article/view/1328/1397Copyright (c) 2024 Rafaella Tortoriello, Natália Lôres Lopes, Bianca Bianco Paschoalino Linhares, Thais Ribeiro Correia, Julio Israel Fernandeshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessTortoriello, RafaellaLopes, Natália LôresLinhares, Bianca Bianco PaschoalinoCorreia, Thais RibeiroFernandes, Julio Israel2024-03-21T13:10:33Zoai:ojs.rbmv.org:article/1328Revistahttps://rbmv.org/BJVMONGhttps://rbmv.org/BJVM/oaicontato.rbmv@gmail.com2527-21790100-2430opendoar:2024-03-21T13:10:33Brazilian Journal of Veterinary Medicine - Sociedade de Medicina Veterinária do Estado do Rio de Janeiro (SOMVERJ)false |
dc.title.none.fl_str_mv |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs Uso do sarolaner no tratamento de tungiase em cães naturalmente infestados |
title |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
spellingShingle |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs Tortoriello, Rafaella Tunga spp., canine, isoxazoline, control, prophylaxis. Tunga spp., canino, isoxazolina, controle, profilaxia. |
title_short |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
title_full |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
title_fullStr |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
title_full_unstemmed |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
title_sort |
Use of sarolaner in the treatment of tungiasis in naturally infested dogs |
author |
Tortoriello, Rafaella |
author_facet |
Tortoriello, Rafaella Lopes, Natália Lôres Linhares, Bianca Bianco Paschoalino Correia, Thais Ribeiro Fernandes, Julio Israel |
author_role |
author |
author2 |
Lopes, Natália Lôres Linhares, Bianca Bianco Paschoalino Correia, Thais Ribeiro Fernandes, Julio Israel |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Tortoriello, Rafaella Lopes, Natália Lôres Linhares, Bianca Bianco Paschoalino Correia, Thais Ribeiro Fernandes, Julio Israel |
dc.subject.por.fl_str_mv |
Tunga spp., canine, isoxazoline, control, prophylaxis. Tunga spp., canino, isoxazolina, controle, profilaxia. |
topic |
Tunga spp., canine, isoxazoline, control, prophylaxis. Tunga spp., canino, isoxazolina, controle, profilaxia. |
description |
Tungiasis is an endemic dermatological parasitic zoonosis in Latin America, caused by the sand flea Tunga spp. (Siphonaptera, Tungidae), which promotes intense discomfort, swelling, erythema, itching, pain, secondary bacterial infection, cellulitis and necrosis. Sarolaner has been used to control different ectoparasites, but there is no record of its use for the treatment of tungiasis in dogs. The objective of this study was to evaluate the effectiveness of sarolaner for the treatment dogs naturally infested by Tunga spp. kept in the same infested environment. Three of four animals were medicated with sarolaner orally with a single dose of 2 mg/kg, as recommended by the manufacturer, and one animal remained without medication. After 24 hours, the fleas from all four dogs were mechanically removed. The animals were reevaluated on days +15 and +30 to assess possible reinfestation. The medicated animals remained free of fleas, while the untreated animal had fleas on the days previously defined for reevaluation. We can thus conclude that the use of sarolaner is an effective choice for tungiasis treatment. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjvm.org.br/BJVM/article/view/1328 10.29374/2527-2179.bjvm000224 |
url |
https://bjvm.org.br/BJVM/article/view/1328 |
identifier_str_mv |
10.29374/2527-2179.bjvm000224 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://bjvm.org.br/BJVM/article/view/1328/1396 https://bjvm.org.br/BJVM/article/view/1328/1397 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/xml |
dc.publisher.none.fl_str_mv |
Sociedade de Medicina Veterinária do Estado do Rio de Janeiro. |
publisher.none.fl_str_mv |
Sociedade de Medicina Veterinária do Estado do Rio de Janeiro. |
dc.source.none.fl_str_mv |
Brazilian Journal of Veterinary Medicine; Vol. 46 (2024); e000224 Revista Brasileira de Medicina Veterinária; v. 46 (2024); e000224 2527-2179 0100-2430 reponame:Brazilian Journal of Veterinary Medicine instname:Sociedade de Medicina Veterinária do Estado do Rio de Janeiro (SOMVERJ) instacron:SBMV |
instname_str |
Sociedade de Medicina Veterinária do Estado do Rio de Janeiro (SOMVERJ) |
instacron_str |
SBMV |
institution |
SBMV |
reponame_str |
Brazilian Journal of Veterinary Medicine |
collection |
Brazilian Journal of Veterinary Medicine |
repository.name.fl_str_mv |
Brazilian Journal of Veterinary Medicine - Sociedade de Medicina Veterinária do Estado do Rio de Janeiro (SOMVERJ) |
repository.mail.fl_str_mv |
contato.rbmv@gmail.com |
_version_ |
1798313106285264896 |